Cumberland Pharmaceuticals Inc.

2.19-0.1600-6.81%Vol 61.40K1Y Perf -24.19%
Aug 16th, 2022 16:00 DELAYED
BID2.09 ASK2.38
Open2.40 Previous Close2.35
Pre-Market- After-Market2.19
 - -  - -%
Target Price
8.50 
Analyst Rating
— 0.00
Potential %
288.13 
Finscreener Ranking
★★★★+     57.53
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
★★★     50.78
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
★+     40.98
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
5.34 
Earnings Rating
Buy
Market Cap32.11M 
Earnings Date
9th Aug 2022
Alpha-0.01 Standard Deviation0.14
Beta0.29 

Today's Price Range

2.192.41

52W Range

1.897.51

5 Year PE Ratio Range

-83.90-14.90

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
-7.59%
1 Month
-2.23%
3 Months
-3.95%
6 Months
-32.20%
1 Year
-24.19%
3 Years
-61.10%
5 Years
-67.46%
10 Years
-63.50%

TickerPriceChg.Chg.%
CPIX2.19-0.1600-6.81
AAPL173.03-0.1600-0.09
GOOG122.51-0.3700-0.30
MSFT292.71-0.7600-0.26
XOM91.46-0.8600-0.93
WFC46.060.31000.68
JNJ167.571.48000.89
FB196.640.99000.51
GE81.071.26001.58
JPM123.631.17000.96
 
ProfitabilityValueIndustryS&P 500US Markets
75.90
-17.50
-3.80
-24.80
-22.17
RevenueValueIndustryS&P 500US Markets
27.57M
1.88
-7.60
-0.71
Earnings HistoryEstimateReportedSurprise %
Q02 2022--0.01-
Q01 2022-0.02-
Q04 2021--0.14-
Q03 2021--0.03-
Q02 2021-0.09-0.0188.89
Q01 2021-0.090.06166.67
Q04 2020-0.03-0.0166.67
Q03 2020-0.090.00100.00
Earnings Per EndEstimateRevision %Trend
9/2021 QR-0.030.00-
12/2021 QR0.060.00-
12/2021 FY0.00--
12/2022 FY0.020.00-
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume61.40K
Shares Outstanding14.66K
Shares Float8.62M
Trades Count393
Dollar Volume139.08K
Avg. Volume10.12K
Avg. Weekly Volume9.79K
Avg. Monthly Volume10.20K
Avg. Quarterly Volume10.38K

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) stock closed at 2.19 per share at the end of the most recent trading day (a -6.81% change compared to the prior day closing price) with a volume of 61.40K shares and market capitalization of 32.11M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 94 people. Cumberland Pharmaceuticals Inc. CEO is A. J. Kazimi.

The one-year performance of Cumberland Pharmaceuticals Inc. stock is -24.19%, while year-to-date (YTD) performance is -53.1%. CPIX stock has a five-year performance of -67.46%. Its 52-week range is between 1.8901 and 7.51, which gives CPIX stock a 52-week price range ratio of 5.34%

Cumberland Pharmaceuticals Inc. currently has a PE ratio of -7.20, a price-to-book (PB) ratio of 0.91, a price-to-sale (PS) ratio of 1.25, a price to cashflow ratio of 9.00, a PEG ratio of 2.32, a ROA of -5.47%, a ROC of -7.90% and a ROE of -11.85%. The company’s profit margin is -22.17%, its EBITDA margin is -3.80%, and its revenue ttm is $27.57 Million , which makes it $1.88 revenue per share.

Of the last four earnings reports from Cumberland Pharmaceuticals Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Cumberland Pharmaceuticals Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Cumberland Pharmaceuticals Inc. is (0), with a target price of $8.5, which is +288.13% compared to the current price. The earnings rating for Cumberland Pharmaceuticals Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cumberland Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Cumberland Pharmaceuticals Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 14.11, ATR14 : 0.15, CCI20 : 21.25, Chaikin Money Flow : -0.30, MACD : 0.03, Money Flow Index : 38.25, ROC : 3.52, RSI : 41.30, STOCH (14,3) : 51.07, STOCH RSI : 0.83, UO : 40.04, Williams %R : -48.93), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cumberland Pharmaceuticals Inc. in the last 12-months were: Caroline R. Young (Buy at a value of $2 598), James R. Jones (Buy at a value of $3 883), Joseph C. Galante (Buy at a value of $7 849), Kenneth J. Krogulski (Buy at a value of $13 115)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating-
0.00
-
0.00
Strong Buy
1.00

Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It focuses on the acquisition, development, and commercialization of branded prescription products. The company provides prescription products to hospital acute care and gastroenterology to address unmet or poorly met medical needs. Its product brands include Acetadote, Caldolor, Kristalose, Omeclamox- Pak, Vaprisol and Ethyol.

CEO: A. J. Kazimi

Telephone: +1 615 255-0068

Address: 2525 West End Avenue, Nashville 37203, TN, US

Number of employees: 94

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

50%50%

Bearish Bullish

52%48%


News

Stocktwits